Syneos Health, Inc.·4

Feb 24, 5:08 PM ET

Olefson Jonathan 4

4 · Syneos Health, Inc. · Filed Feb 24, 2023

Insider Transaction Report

Form 4
Period: 2023-02-23
Olefson Jonathan
General Counsel & Corp Secty
Transactions
  • Award

    Class A Common Stock

    2023-02-23+60266,206 total
  • Tax Payment

    Class A Common Stock

    2023-02-23$38.25/sh2,001$76,53864,205 total
  • Award

    Class A Common Stock

    2023-02-23+2,60964,713 total
  • Award

    Class A Common Stock

    2023-02-23+89165,604 total
Footnotes (3)
  • [F1]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022.
  • [F2]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full on the date on which the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.
  • [F3]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2024, subject to continued employment.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION